In brief
The U.S. freeze on foreign aid has left many, including Dalvin Modore, unable to access crucial tuberculosis treatment, risking a resurgence of the disease worldwide.
Dalvin Modore, a 40-year-old farmer from western Kenya, steps cautiously as he battles tuberculosis (TB), a disease that has surged recently due to a significant cut in U.S. funding. Weighing just 110 pounds and suffering from a persistent cough, Dalvin’s experience is reflective of many across Kenya and globally who are now devoid of critical treatment resources.Since the Trump administration decided to freeze foreign aid on January 20, a vast network dedicated to diagnosing and treating TB has crumbled, particularly in Africa and Asia, where TB remains the leading cause of infectious disease-related deaths. The U.S. was previously responsible for nearly half of all donor funding for TB, covering essential needs from laboratory equipment to nursing staff.Patients like Dalvin now struggle to find necessary medications and tests, resulting in perilous health conditions and an increased risk of spreading the infection. The federal officials argue that other nations should step up their contributions to global health initiatives, although the immediate consequences of this funding halt present escalating health crises for those most vulnerable. The world is now on a concerning path as TB resurfaces, underlined by the stark realities faced by individuals on the ground.
